Livzon Pharmaceutical Group
OverviewSuggest Edit
Livzon Pharmaceutical Group (丽珠医药) is a company that specializes in the development and production of active pharmaceutical ingredients (APIs), biological drugs, diagnostic reagents, and other products. It focuses on a range of therapeutic areas, including gastroenterology, gynecology, neurology, cardiology, etc.
| Type | Public | |
| Founded | 1985 | |
| Website | livzon.com.cn |
Livzon Pharmaceutical Group Financials and Metrics
Livzon Pharmaceutical Group Revenue
Market capitalization (7-May-2021) | 36.7b |
Closing stock price (7-May-2021) | 44.5 |
Livzon Pharmaceutical Group's current market capitalization is ¥36.7 b.
Livzon Pharmaceutical Group Cybersecurity Score
Livzon Pharmaceutical Group Environment, Social & Governance (ESG) Ratings
Livzon Pharmaceutical Group Online and Social Media Presence
Livzon Pharmaceutical Group's Trends
Livzon Pharmaceutical Group Frequently Asked Questions
When was Livzon Pharmaceutical Group founded?
Livzon Pharmaceutical Group was founded in 1985.
How many employees does Livzon Pharmaceutical Group have?
Livzon Pharmaceutical Group has 9,019 employees.
Who are Livzon Pharmaceutical Group competitors?
Competitors of Livzon Pharmaceutical Group include YiChang HEC ChangJiang Pharmaceutical, Hanmi Pharmaceutical and Chiesi Group.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies